Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2026-02-10 | New | $2,162,300 | $2,162,300 | Other | 06b | SEC link |
| Name | Role |
|---|---|
| Ivan Alex Priela Lazarte | Director, Executive |
| Gabriel Ocana Santero | Director, Executive |
| Marko Tvrdic | Director, Executive |